Migraine crystal ball: study aims to predict treatment success
NCT ID NCT06459648
First seen Jun 24, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This study is looking for ways to predict which migraine patients will respond well to a class of drugs called anti-CGRP monoclonal antibodies. Researchers will analyze clinical, biological, and brain imaging data from 350 adults with frequent migraines. The goal is to find biomarkers that help doctors choose the right treatment from the start, reducing trial-and-error and improving patients' quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Anti-CGRP monoclonal antibodies (Erenumab, Galcanezumab, Fremanezumab, Eptinezumab)
- What this could lead to
- If successful, this could help doctors predict which migraine treatment will work best for each patient, saving time and improving quality of life.
- What could go wrong
- This is an observational study, not a treatment trial. It may not find clear predictors, and results may not apply to all migraine patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Hospital Clínico Universitario Lozano Blesa
RECRUITINGZaragoza, Aragon, 50009, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hospital Clínico Universitario de Valladolid
RECRUITINGValladolid, Castille and León, 47010, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Hospital Universitari Vall d'Hebron Research Institute
RECRUITINGBarcelona, Catalonia, 08035, Spain
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hospital Universitario Donostia
RECRUITINGDonostia / San Sebastian, Basque Country, 20014, Spain
Contact Email: •••••@•••••
Contact
-
Hospital Universitario Marqués de Valdecilla
RECRUITINGSantander, Cantabria, 39008, Spain
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hospital Universitario Politécnico La Fe
RECRUITINGValencia, Valencia, 46026, Spain
Contact Email: •••••@•••••
Contact
-
Hospital Universitario de La Princesa
RECRUITINGMadrid, Madrid, 28006, Spain
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mind over migraine: brain network may explain why some expect side effects
- The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?
- Experimental migraine drug JS010 takes first step in human safety trial
- Scientists probe shared pain pathways in endometriosis and migraine
- Brain scans and heat tests may predict migraine in teens
- Could a simple diary ease the burden of migraine?